Thursday 22 November 2018

Veterinary Reference Laboratories (VRL) Market Expected To Trigger A Revenue Increase To 5.13 Billion By 2025:Key Participant IDEXX Laboratories, Inc., VCA, Inc.


San Francisco, 22 November 2018,  The global veterinaryreference laboratories (VRL) market is expected to reach USD 5.13 billion by 2025, according to a new report by Grand View Research, Inc. Increase in incidence of zoonotic diseases is a key driving factor for market growth. Increase in adoption of integrated diagnostic systems coupled with information ecosystems for veterinary diagnostics is anticipated to fuel development.
Rise in demand for advanced diagnostic tests and growing awareness amongst consumers are some of the factors expected to boostdemandover the coming years. Moreover, companies are investing in R&D for the advancement of test kits for cost-effective diagnosis & monitoring of animal health, which is expected to boost growth. Some of the advancements in this market include efficient information management systems used in animal diagnostic applications, vaccine banks, and mobile apps for continuous monitoring. High focus toward innovation in veterinary health is anticipated to fuel the demand for reference labs. For instance, Innovative Medicines Initiative (IMI) is a public-private partnership that supports pharmaceutical innovations in Europe.
In addition, MediLabSecure, a laboratory network project was established, which aims to identify emerging viruses& pathogens in 19 countries in the Mediterranean regions and 57 labs were involved. Furthermore, increase in the number of government initiatives to promote veterinary diagnostics products is presumed to drive the overall growth. 
Access Full Research Report On Veterinary Reference Laboratories (VRL) Market Analysis:

Further Key Findings From the Study Suggest:
·         The clinical chemistry analyzers segment held the dominant share of the market as of 2016 owing to growing demand for veterinary diagnostics products
·         Increase ininstances of contamination in pet foods that causesevere illnesses and deaths amongst animalsis expected to boost the demand for toxicology testing services
·         Production animals accounted for largest revenue share in 2016 owing to their highest consumption rate
·         The market was dominated by North America and is expected to retain its position throughout the forecast period
·         Presence of prominent industry players, advanced healthcare infrastructure, and high healthcare expenditure are some of the factors responsible for growth
·         Companies offering reference laboratories are focusing on the development of cost-effective diagnostic solutions for animal health
·         IDEXX Laboratories, Inc. held a dominant share owing to its presence across the globe and a wide product portfolio of advanced diagnostic tests
·         Strategies such as regional expansion, new product developments, merger & acquisitions, and research collaborations are anticipated to propel growth
·         For instance, inJanuary 2017, Mars, Inc. announced the agreement for acquiring VCA Inc. in a probe to capture higher share
Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/healthcare

Grand View Research has segmented VRL market on the basis of the technology, application, animal type,and region:
VRL Technology Outlook (Revenue, USD Million, 2014 - 2025)
·         Clinical Chemistry
·         Hematology
·         Immunodiagnostics
o    ELISA
o    Lateral Flow Rapid Tests
o    Others
·         Molecular Diagnostics
o    PCR
o    Microarrays
o    Others
·         Others
VRL Application Outlook (Revenue, USD Million, 2014 - 2025)
·         Clinical Pathology
·         Toxicology
·         Productivity Testing
·         Others
VRL Animal Type Outlook (Revenue, USD Million, 2014 - 2025)
·         Production
·         Companion
VRL Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    U.K.
o    Germany
·         Asia Pacific
o    Japan
o    China
o    India
·         Latin America
o    Mexico
o    Brazil
·         MEA
o    South Africa


About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/



at No comments:
Labels: , , , , , , , , ,

Hemodialysis And Peritoneal Dialysis Market Expected To Trigger A Revenue Increase To 108.5 Billion By 2025:Key Participant TETRA Technologies, M-I SWACO


San Francisco, 22 November 2018, The global hemodialysis and peritoneal dialysis market is expected to reach USD 108.5 billion by 2025, according to a new report by Grand View Research, Inc. Home-based dialysis treatment is anticipated to witness lucrative growth over the forecast period. Factors supporting this trend include; increasing development of small and automated products capable of providing treatment at home, rising number of individuals requiring daily procedures, growing number of individuals aptly trained to perform self-treatment, and initiatives by market participants toward raising education and training for home dialysis performance.
This industry is highly competitive with a few players holding relatively high proportion of the market share. However, the dominance of each player is in a separate region thereby limiting direct competition. For instance, Baxter generates higher revenue in Europe whereas Fresenius Medical Care AG & Co. KGaA gains higher revenue in the U.S. This scenario is anticipated to change over the forecast period owing to increasing globalization, and efforts by companies to expand their revenues and profits.
Access Full Research Report On Hemodialysis And Peritoneal Dialysis Market Analysis:

Further key findings from the study suggest:
·         Hemodialysis dominates the industry with over 80.0% of the market share. These processes are performed in centers as well as in home settings primarily for adults. This enhanced applicability and benefits in comparison to peritoneal dialysis are expected to promote growth.
·         Presence of treatment centers and skilled personnel in abundance to carry out procedures is expected to drive the growth for these services. Factors responsible for higher market share of services may be classified into rising number of centers, development of training courses for home-based patients, and rising number of patients requiring dialysis treatment.
·         Home-based procedures are anticipated to witness the fastest growth over the forecast period. Development of small & portable systems along with with rising healthcare literacy amongst patients are vital impact rendering drivers.
·         Regionally, Asia Pacific is predicted to contribute higher revenue share over the forecast period. Improving healthcare infrastructure, rising disposable income, and growing incidence of conditions such as diabetes within the region are expected to support growth.
·         Players highlighted in the study include Fresenius Medical Care AG & Co. KGaA, NIPRO Medical Corporation, B. Braun Avitum AG, Baxter, and DaVita Inc. These companies are aggressively working toward purchasing dialysis centers or establishing new centers to cater to the rising demand.
Browse More Reports Of This Category By Grand View Research At:   www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global hemodialysis and peritoneal dialysis market on the basis of type, product, end-use, and region:
Global Hemodialysis And Peritoneal Dialysis Type Outlook (Revenue, USD Million, 2014-2025)
·         Hemodialysis
o    Conventional
o    Short Daily
o    Nocturnal
·         Peritoneal Dialysis
o    CAPD
o    APD
Global Hemodialysis And Peritoneal Dialysis Product Outlook (Revenue, USD Million, 2014-2025)
·         Device
o    Machine
o    Dialyzers
o    Water Treatment System
o    Others
·         Consumables
o    Bloodline
o    Concentrates
o    Catheters
o    Others
·         Services
Global Hemodialysis And Peritoneal Dialysis End-use Outlook (Revenue, USD Million, 2014-2025)
·         Home-based
·         Hospital-based
Hemodialysis And Peritoneal Dialysis Regional Outlook (Revenue, USD Million, 2014-2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    UK
o    Germany
·         Asia Pacific
o    Japan
o    China
·         Latin America
o    Brazil
o    Mexico
·         Middle East and Africa (MEA)
o    South Africa

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/

at No comments:
Labels: , , , ,

Clear Brine Fluids Market Expected To Trigger A Revenue Increase To 926.7 Million By 2020:Key Participant TETRA Technologies, M-I SWACO


San Francisco, 22 November 2018, In 2013, the global clearbrine fluids market was worth USD 926.7 million. As of May 2013, the count for global rig was noted to be around 3,400. This increase in drilling activities has driven the demand for global rig count which has also contributed to fuel the growth of clear brine fluids market across the globe.
Move towards the growth of alternative energy resources such as CBM, tight gas, and shale gas mainly in China and the U.S. is anticipated to drive the growth of the global market. The Golden Triangle denotes oil & gas reserves of deep water wrapping offshore Brazil, offshore West Africa and the U.S. Gulf of Mexico (USGOM). Moreover, increased investment for deep water investigation mainly in the region is also projected to increase the demand for global clear brine fluids market. Egypt, Gulf of Mexico, the U.S., China, and Russia experienced increased drilling activities on account of rising demand for energy which is likely to drive the market.
Potassium chloride consumption accounted for over 20% of the global market in 2013. This was the largest product segment in the same year and is also anticipated to have the highest growth rate of over 10% from 2014 to 2020. Potassium chloride is most widely used for servicing wells in oil & gas industry. Wide applications range of all the bromides and chloride are expected to drive the global market. These are favored above conventional drilling muds on account of their effectiveness and cost efficiency. Primary applications of potassium chloride and bromide fluids take account of deep water wells, high & deep pressure oil sands and oil wells where general drilling muds are susceptible to block the foundations.
North America accounted for over 60% of the global clear brine fluids market in 2013. Shale gas flourishing in the U.S. is projected to provide the region with an upper hand over the forecast period. Asia Pacific market is anticipated to experience highest growth rate in production capabilities of over 10% from 2014 to 2020. Growing exploration activities in India along with the thriving oil & gas segment is projected to further boost the growth of clear brine fluids market in the region.
The global clear brine fluids market is amalgamated with four companies leading the market with over 50% market share and is characterized by a high threat of new entrants. Major industry participants include TETRA Technologies, M-I SWACO, Israel Chemicals Ltd., Halliburton, Albemarle Corporation and Great Lake Solutions. These companies are taking steps to gain a competitive advantage and to increase their product line.
Access Full Research Report On Clear Brine Fluids Market Analysis:
www.grandviewresearch.com/industry-analysis/clear-brine-fluids-market

Further key findings from the study suggest:
·         Global clear brine fluids market demand was 1,010.2 kilo tons in 2013 and is expected to reach 1,977.5 kilo tons by 2020, growing at a CAGR of 10.1% from 2014 to 2020.
·         North America emerged as the leading regional market for clear brine fluids and accounted for 64.9% of total market volume in 2013. Increasing drilling activities in the U.S. on account of shale gas boom and in Gulf of Mexico remained a key driving factor for the regional market.
·         Asia Pacific is expected to witness the highest growth at 11% over the next six years.  Increasing drilling activities in China on account of presence of large amount of untapped shale gas in place is expected to remain a key driving factor for the regional market. European clear brine fluids market is expected to reach USD 162.3 million by 2020, growing at a CAGR of 12% from 2014 to 2020.
·         Global clear brine fluids market is moderately concentrated with top four companies including M-I SWACO, Halliburton, Israel Chemicals Ltd., TETRA Technologies accounted for over 50% of the total market. Other market participants include Albemarle Corporation, Baker Hughes Inc., Zirax Ltd., The Egyptian Mud Engineering & Chemicals Co., GEO Drilling Fluids Inc., Newpark Resources Inc. and Chemtura Corporation. Clear brine fluids market recently, witnessed number of mergers and acquisitions leading to significant opportunities for market participants.
Browse More Reports Of This Category By Grand View Research At:   www.grandviewresearch.com/industry/petrochemicals-and-downstream-derivatives
Grand View Research has segmented the clear brine fluids market on the basis of product and region:
Global Clear Brine Fluids Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2020)
·         Potassium Chloride
·         Calcium Chloride
·         Sodium Chloride
·         Potassium Bromide
·         Calcium Bromide
·         Sodium Bromide
·         Others
Global Clear Brine Fluids Regional Outlook (Volume Kilo Tons; Revenue, USD Million, 2012 - 2020)
·         North America
·         Europe
·         Asia Pacific
·         RoW

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/


at No comments:
Labels: , , , ,

Acne Drugs Market Expected To Trigger A Revenue Increase To 5.9 Billion By 2025:Key Participant Allergan, Bayer

San Francisco, 22 November 2018, The global acne drugs market size is expected to reach USD 5.9 billion by 2025, according to a new report by Grand View Research, Inc., registering a 4.2% CAGR during the forecast period. Several factors such as emergence of biologics, unhealthy lifestyle, and rising disease incidence are anticipated to drive the market.
Acne vulgaris is one of the most common dermatological disorders, affecting 9.4% people worldwide. Although the condition can affect people of all ages, it is most prevalent among teenagers. It has been found that the condition is prevalent in more than 85.0% people between the ages of 12 and 25. Acne can appear in forms ranging from comedones to cystic lesions, depending on its severity.
Retinoids and antibiotics remain the mainstays of acne treatment. Retinoids led the therapeutic classes in 2017, and it is expected to continue this trend through 2025. The therapeutic landscape is witnessing a shift toward combination treatment due to higher efficacy, convenient dosing, and fewer adverse effects.
By mode of administration, topical drugs currently dominate the market. Severe cases see the use of systemic medications such as oral antibiotics, hormonal agents, or other drugs. However, emergence of biologics (Gevokizumab and RA-18C3) will fuel the injectable route of administration. Biologics offer improved clinical advantage over conventional topical treatments since they target inflammatory mechanisms with disease modifying ability.
Discontinuation or termination of key pipeline candidates on account of unsuccessful clinical trials is a major restraint this market faces. Upon launch, Olumacostat glasaretil (Dermira; topical lipid synthesis inhibitor) was expected to be the first topical anti-acne drug with isotretinoin-like results without significant side effects. However, the drug failed to meet clinical endpoints, leading to discontinuation in March 2018. Similarly, SNA-001 (Sienna; silver nanoparticles solution) was deemed unsuccessful in two key trials wherein it was tested in conjunction with 810nm and 1064nm lasers in July 2018. Thesan withdrew TSN2898 from Phase II trials due to drug unavailability. Xenon discontinued development of XEN801 after the drug failed Phase II clinical trials.
Despite being one of the most common dermatological diseases in the world, innovation in acne treatment has been rather limited over the past decade. Drug companies are currently exploring novel treatment approaches including stearoyl CoA desaturase inhibition, melanocortin receptor antagonism, and anti-IL-1 monoclonal antibodies. Impending launch of late-stage pipeline products indicate a promising future for the global acne drugs market.
Access Full Research Report On Acne Drugs Market Analysis:www.grandviewresearch.com/industry-analysis/acne-drugs-market

Further key findings from the report suggest:
  • By type, inflammatory acne captured more than 50.0% of the market in 2017. Comedonal acne were ranked second-largest, among other types
  • On the basis of therapeutic class, retinoids led the market in 2017, followed by antibiotics. This trend is likely to continue through 2025
  • The treatment paradigm is shifting toward combination therapies and biologics. Combination products are gaining traction due to higher efficacy, convenient dosing, and fewer adverse effects
  • Topical products dominated the treatment landscape, based on mode of administration. However, introduction of biologics is likely to result in the growth of the injectables segment
  • S. dominated the major markets and is projected to maintain its lead through 2025, owing to rising disease incidence and ease of access to anti-acne products
  • Allergan, Bayer, Galderma, Stiefel, and Valeant are some key players operating in this market. Valeant is projected to lead the market in 2025 due to higher adoption of Retin-A micro as well as anticipated launch of pipeline candidates.
Browse More Reports Of This Category By Grand View Research At:   www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the global acne drugs market based on type, therapeutic class, mode of administration, and country:
Acne Drugs Type Outlook (Revenue, USD Million, 2017 - 2025)
  • Comedonal
  • Inflammatory
  • Cystic
  • Post-surgical/Wound
Acne Drugs Therapeutic Class Outlook (Revenue, USD Million, 2017 - 2025)
  • Retinoid
  • Antibiotic
  • Hormonal Agent
  • Combination
  • Others
Acne Drugs Mode of Administration Outlook (Revenue, USD Million, 2017 - 2025)
  • Topical
  • Oral
  • Injectable
Acne Drugs Country Outlook (Revenue, USD Million, 2017 - 2025)
  • U.S.
  • U.K.
  • Germany
  • Spain
  • France
  • Italy
  • Japan
Access Full Press Release of this Report: https://www.grandviewresearch.com/press-release/global-acne-drugs-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/

at No comments:
Labels: , , , ,
Subscribe to: Posts (Atom)